Enjoy complimentary customisation on priority with our Enterprise License!
The plethysmograph market size is forecast to increase by USD 18 billion at a CAGR of 3.2% between 2023 and 2028. The plethysmography market is experiencing significant growth due to the increasing prevalence of respiratory diseases such as COPD, asthma, and pulmonary fibrosis in the geriatric population. According to revenue data, the market is expected to expand at a steady pace, driven by the advent of next-generation plethysmographs that offer improved accuracy and patient comfort. However, the market faces challenges due to the limitations and complications associated with plethysmographs, including the need for specialized technicians and high costs. These factors, coupled with the rising burden of respiratory diseases, present both opportunities and challenges for market participants. To stay competitive, companies must focus on developing user-friendly and cost-effective solutions that address the needs of healthcare providers and patients alike.
The market is witnessing significant growth due to the increasing prevalence of respiratory diseases such as asthma and pulmonary fibrosis. These conditions require accurate and timely diagnosis, leading to high demand for non-invasive lung function tests. The manufacturing process of plethysmographs involves the use of advanced technology and high-quality raw materials. Key components include pressure transducers, volume sensors, and data acquisition systems. These components are sourced from reputed suppliers to ensure accuracy and reliability. Plethysmographs occupy a crucial position in the healthcare industry, particularly in hospitals and clinics.
They are used for evaluating lung function, which is essential for early diagnosis and effective treatment of respiratory diseases. Body plethysmographs and lung plethysmographs are the two main types, each catering to specific diagnostic needs. Applications in Asthma and Pulmonary Fibrosis: Asthma and pulmonary fibrosis are two common respiratory conditions where plethysmographs play a vital role. Asthma is a chronic inflammatory disorder characterized by recurrent episodes of breathlessness, chest tightness, and coughing. Plethysmography helps in assessing lung function, guiding treatment, and monitoring disease progression. Pulmonary fibrosis, on the other hand, is a progressive fibrosis of the interstitium of the lungs, leading to impaired gas exchange.
Plethysmography aids in diagnosing this condition and evaluating the response to treatment. High Demand and Challenges: The high demand for plethysmographs in the healthcare industry is driven by the need for non-invasive, accurate, and reliable lung function tests. However, the high cost and requirement for trained personnel are some of the challenges limiting market growth. Hospitals and clinics invest in these devices to cater to the growing patient base and improve patient care. Asia Pacific is also emerging as a significant market due to the growing healthcare sector and rising disposable income. In conclusion, the market is experiencing steady growth due to the increasing demand for non-invasive lung function tests in the healthcare industry. The market is driven by the need for accurate and reliable diagnostic tools for respiratory diseases such as asthma and pulmonary fibrosis. Despite the challenges of high cost and requirement for trained personnel, the market is expected to continue growing due to the increasing prevalence of respiratory conditions and the importance of early diagnosis and effective treatment.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The hospitals segment is estimated to witness significant growth during the forecast period. Hospitals play a pivotal role in providing advanced diagnostic services to patients with intricate medical conditions. This healthcare institutions house specialized diagnostic centers staffed with skilled technicians and state-of-the-art equipment. One such diagnostic test offered in hospitals is plethysmography, which assesses lung function. The demand for plethysmography is high due to the early diagnosis and effective treatment of respiratory disorders. However, the high cost associated with this diagnostic tool and the need for trained personnel limit its widespread use. Hospitals contribute significantly to the global market for plethysmographs, fueled by the increasing incidence of acute and chronic diseases and the availability of highly specialized pulmonologists. The diagnostic departments in hospitals, including microbiology, histopathology, radiology, and biochemistry, utilize plethysmographs to diagnose and monitor respiratory conditions, ensuring optimal patient care.
Get a glance at the market share of various segments Request Free Sample
The Hospitals segment accounted for USD 39.80 million in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
In the North American market, the United States holds a significant position in the plethysmograph industry due to the increasing prevalence of respiratory disorders like asthma and COPD. According to the Centers for Disease Control and Prevention (CDC), approximately 5% of the US population was diagnosed with COPD, emphysema, and bronchitis in 2020. The American Academy of Respiratory Care (AARC) is a prominent organization that advocates for the use of advanced diagnostic devices, including plethysmographs, to improve patient outcomes. The AARC emphasizes the advantages of plethysmography over traditional gas dilution techniques. Additionally, the American Thoracic Society (ATS), founded in 1905, plays a crucial role in advancing the clinical and scientific understanding of pulmonary diseases, critical illnesses, and sleep-related breathing disorders.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Increasing incidence and prevalence of lung and vascular diseases is the key driver of the market. Plethysmographs play a crucial role in financial analysis within the healthcare industry due to their application in diagnosing lung and vascular diseases, which are major contributors to global mortality and morbidity. The rising incidence and prevalence of conditions such as deep vein thrombosis, pulmonary embolism, asthma, and chronic obstructive pulmonary disease are driving the demand for these diagnostic tools. The value chain of the market involves various stakeholders, including manufacturers, distributors, suppliers, and end-users. Patent analysis is an essential component of market insights, as it provides information on the intellectual property landscape and competitive dynamics. The evaluation quadrant is a valuable tool for investors and businesses seeking to understand the competitive landscape and identify potential investment opportunities.
Region analysis is another essential aspect of market research, providing insights into market trends, growth potential, and regulatory environments in different geographical areas. Key factors driving the growth of the market include the increasing burden of lung and vascular diseases, the need for early diagnosis and regular monitoring, and advancements in technology.
Advent of next-generation plethysmographs is the upcoming trend in the market. The market is experiencing growth due to the increasing demand for advanced diagnosis equipment for respiratory diseases, particularly among the geriatric population. Next-generation plethysmographs, which feature innovative hardware designs and sophisticated software, are gaining popularity in the market. These devices offer more accurate results than conventional plethysmographs, reducing the risk of misinterpretation. For example, PulmOne Advanced Medical Devices' MiniBox plus is a groundbreaking tabletop device that provides comprehensive Pulmonary Function Tests (PFT), including whole-body plethysmography, spirometry, and diffusion testing. This desktop, gasless device is widely used in clinical settings for diagnosing conditions such as Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Pulmonary Fibrosis. The market's growth is further driven by the rising prevalence of respiratory diseases and the increasing focus on improving diagnostic accuracy.
Limitations and complications associated with plethysmographs is a key challenge affecting the market growth. A body plethysmograph is a diagnostic tool utilized in the medical field to assess the function of a person's lungs and vascular system. It is particularly beneficial for identifying conditions such as chest wall pain and impaired lung expansion or contraction, which can result in breathing difficulties. However, it is important to note that a plethysmograph does not determine the underlying cause of lung or vascular diseases. The manufacturing process of a plethysmograph involves the use of raw materials like sensors, pressure transducers, and valves. The product position in the market is primarily focused on the adult segment due to the prevalence of lung and vascular diseases among this demographic.
When building a strategy model for the market, it is essential to consider the historical period and potential future trends. One significant challenge is the presence of external factors that can impact the accuracy of the results, such as patient movement and compressible materials within the plethysmography chambers. Additionally, there is a risk of complications from arterial punctures during the diagnostic process, including thrombosis, artery spasm, bleeding, or hematoma. In conclusion, the body plethysmograph plays a crucial role in diagnosing and monitoring lung and vascular diseases, but it is essential to be aware of the potential challenges and complications associated with its use.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
ACI Medical LLC - The company provides the APG Air Plethysmograph, a leading solution in the market. This innovative tool measures volumetric changes in body parts, primarily used for assessing respiratory function and pulmonary disorders. It delivers precise and reliable results, ensuring accurate diagnosis and effective treatment plans. The APG Air Plethysmograph is an essential tool for healthcare professionals, contributing significantly to the field of respiratory diagnostics.
The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market is a significant sector in the financial analysis of diagnostic equipment, offering valuable insights into the industry's growth and trends. The value chain of plethysmographs includes raw materials, manufacturing process, and product positioning. Patent analysis and evaluation quadrant are crucial tools for strategic analysis in this market. Body plethysmographs and lung plethysmographs are essential diagnostic tools for respiratory diseases such as COPD, asthma, and pulmonary fibrosis. The adult segment is the primary consumer, driven by the high demand for early diagnosis and treatment of these conditions. The geriatric population is another significant market for plethysmographs due to the high prevalence of respiratory diseases among older adults.
The macro market analysis reveals high revenue data and trends in the market. Secondary drivers include the early diagnosis of respiratory diseases, the high cost of treatment, and the need for trained personnel. The market is witnessing expansions, acquisitions, and major collaborations to address the supply-demand gap and meet the increasing demand for plethysmographs. The geographical analysis of the market includes regions with high prevalence rates of respiratory diseases and a growing healthcare infrastructure. Trending innovations, business policies, and merger & acquisitions are shaping the market's future strategies. New developments and strategies aim to improve the accuracy and affordability of plethysmographs while addressing the challenges of supply forces and meeting the needs of hospitals and clinics.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
161 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 3.2% |
|
Market growth 2024-2028 |
USD 18 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
3.03 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 43% |
|
Key countries |
US, China, Germany, Canada, and France |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
ACI Medical LLC, BioTekna Srl, Bonther Equipamentos para Ensino e Pesquisa, COSMED Srl, D. E. Hokanson Inc., Geratherm Medical AG, Medical Electronic Construction, medical equipment Europe GmbH, Medizinische Messtechnik GmbH, MGC Diagnostics Corp., Morgan Scientific Inc., Piston Ltd., PulmOne Advanced Medical Devices Ltd., SCHILLER AG, SCIREQ Scientific Respiratory Equipment Inc., Shanghai TOW Intelligent Technology Co. Ltd., and Vyaire Medical Inc. |
|
Market dynamics |
Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
|
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
